Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Autolus Therapeutics (AUTL) Total Liabilities (2017 - 2025)

Historic Total Liabilities for Autolus Therapeutics (AUTL) over the last 9 years, with Q3 2025 value amounting to $396.5 million.

  • Autolus Therapeutics' Total Liabilities rose 1311.46% to $396.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $396.5 million, marking a year-over-year increase of 1311.46%. This contributed to the annual value of $355.4 million for FY2024, which is 3466.87% up from last year.
  • Per Autolus Therapeutics' latest filing, its Total Liabilities stood at $396.5 million for Q3 2025, which was up 1311.46% from $374.5 million recorded in Q2 2025.
  • Autolus Therapeutics' Total Liabilities' 5-year high stood at $396.5 million during Q3 2025, with a 5-year trough of $47.0 million in Q2 2021.
  • In the last 5 years, Autolus Therapeutics' Total Liabilities had a median value of $221.7 million in 2023 and averaged $217.3 million.
  • As far as peak fluctuations go, Autolus Therapeutics' Total Liabilities tumbled by 3533.25% in 2021, and later soared by 12287.06% in 2023.
  • Quarter analysis of 5 years shows Autolus Therapeutics' Total Liabilities stood at $92.2 million in 2021, then soared by 107.72% to $191.6 million in 2022, then skyrocketed by 37.74% to $263.9 million in 2023, then skyrocketed by 34.67% to $355.4 million in 2024, then grew by 11.56% to $396.5 million in 2025.
  • Its Total Liabilities stands at $396.5 million for Q3 2025, versus $374.5 million for Q2 2025 and $375.2 million for Q1 2025.